These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12119351)

  • 1. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo.
    Ford MS; Young KJ; Zhang Z; Ohashi PS; Zhang L
    J Exp Med; 2002 Jul; 196(2):261-7. PubMed ID: 12119351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells.
    Priatel JJ; Utting O; Teh HS
    J Immunol; 2001 Dec; 167(11):6188-94. PubMed ID: 11714779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An allogeneic microenvironment influences the phenotype of intermediate T-cell receptor cells expanding in MRL-lpr/lpr mice.
    Tsukahara A; Iiai T; Moroda T; Tada T; Suzuki S; Takeda K; Hatakeyama K; Abo T
    Immunology; 1998 Jun; 94(2):149-59. PubMed ID: 9741335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
    J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas ligand costimulates the in vivo proliferation of CD8+ T cells.
    Suzuki I; Martin S; Boursalian TE; Beers C; Fink PJ
    J Immunol; 2000 Nov; 165(10):5537-43. PubMed ID: 11067907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway.
    Zhang ZX; Ma Y; Wang H; Arp J; Jiang J; Huang X; He KM; Garcia B; Madrenas J; Zhong R
    J Immunol; 2006 Nov; 177(10):6920-9. PubMed ID: 17082607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Novicio C; Guarraia D; Dale JK; Straus SE; Fleisher TA
    Clin Immunol; 2002 Jul; 104(1):21-30. PubMed ID: 12139944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver sinusoidal endothelial cells tolerize T cells across MHC barriers in mice.
    Onoe T; Ohdan H; Tokita D; Shishida M; Tanaka Y; Hara H; Zhou W; Ishiyama K; Mitsuta H; Ide K; Asahara T
    J Immunol; 2005 Jul; 175(1):139-46. PubMed ID: 15972640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.